These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9073318)

  • 41. A Sophism in Vectorology: Turning Harmful Defective Retroviral Vectors into Helpful Replication-Competent Retroviruses Against Cancer.
    Klatzmann D
    Hum Gene Ther; 2017 Nov; 28(11):954-957. PubMed ID: 29035117
    [No Abstract]   [Full Text] [Related]  

  • 42. Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.
    Hernandez-Alcoceba R; Poutou J; Ballesteros-Briones MC; Smerdou C
    Immunotherapy; 2016 Feb; 8(2):179-98. PubMed ID: 26786809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies.
    Wang K; Kievit FM; Zhang M
    Pharmacol Res; 2016 Dec; 114():56-66. PubMed ID: 27771464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene therapy for head and neck cancer.
    Clayman GL
    Head Neck; 1995; 17(6):535-41. PubMed ID: 8847213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RNA activation: promise as a new weapon against cancer.
    Zheng L; Wang L; Gan J; Zhang H
    Cancer Lett; 2014 Dec; 355(1):18-24. PubMed ID: 25261049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gendicine: the first commercial gene therapy product.
    Wilson JM
    Hum Gene Ther; 2005 Sep; 16(9):1014-5. PubMed ID: 16149899
    [No Abstract]   [Full Text] [Related]  

  • 47. The standpoint of gene therapy programs.
    Romano G
    Drug News Perspect; 2007 Jun; 20(5):335-43. PubMed ID: 17878962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gene therapy: current status and promise].
    Kaneda Y
    Nihon Yakurigaku Zasshi; 2001 Apr; 117(4):299-306. PubMed ID: 11338380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene therapy strategies for tumor antiangiogenesis.
    Kong HL; Crystal RG
    J Natl Cancer Inst; 1998 Feb; 90(4):273-86. PubMed ID: 9486813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The principles and promising future of sonogenetics for precision medicine.
    Wu P; Liu Z; Tao W; Lai Y; Yang G; Yuan L
    Theranostics; 2024; 14(12):4806-4821. PubMed ID: 39239514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanovesicular Formulations for Cancer Gene Therapy.
    Tavano L; Mazzotta E; Muzzalupo R
    Curr Pharm Des; 2017; 23(35):5327-5335. PubMed ID: 28741454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Beating cancer with synthetic genes: towards more effective treatments through autonomous genetic programs].
    Morel M
    Med Sci (Paris); 2017; 33(6-7):591-593. PubMed ID: 28990556
    [No Abstract]   [Full Text] [Related]  

  • 54. [Gene therapy in orthopaedic surgery].
    Madry H; Kohn D; Cucchiarini M
    Orthopade; 2006 Nov; 35(11):1193-202; quiz 1203. PubMed ID: 17061078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Application of microorganisms as delivery vehicles in cancer gene therapies].
    Łepeta K; Łasica AM; Jagusztyn-Krynicka EK
    Postepy Biochem; 2012; 58(3):314-26. PubMed ID: 23373417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Gene therapy of childhood cancers: current status and perspectives].
    Rousseau R; Biagi E; Bollard C; Brenner M
    Bull Cancer; 2003 Mar; 90(3):227-38. PubMed ID: 12801825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-viral vectors in cancer gene therapy: principles and progress.
    Schatzlein AG
    Anticancer Drugs; 2001 Apr; 12(4):275-304. PubMed ID: 11335785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies used in the clinical trials of gene therapy for cancer.
    Ajith TA
    J Exp Ther Oncol; 2015; 11(1):33-9. PubMed ID: 26259388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The biology of cancer gene therapy.
    Whartenby KA; Abboud CN; Marrogi AJ; Ramesh R; Freeman SM
    Lab Invest; 1995 Feb; 72(2):131-45. PubMed ID: 7853848
    [No Abstract]   [Full Text] [Related]  

  • 60. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.
    Rupaimoole R; Slack FJ
    Nat Rev Drug Discov; 2017 Mar; 16(3):203-222. PubMed ID: 28209991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.